Q1 2024 Avadel Pharmaceuticals PLC Earnings Call Transcript

May 08, 2024 / 12:30PM GMT
Operator

Greetings, and welcome to Avadel Pharmaceuticals' First Quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce Austin Murtagh with Stern Investor Relations. Thank you. You may begin.

Austin Murtagh - Stern Investor Relations - IR

Good morning and thank you for joining us on our conference call to discuss Avadel's First Quarter 2024 earnings. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statement. These risks and uncertainties are described in Avadel's public filings under the Exchange Act included in the Form 10-K for the year ended December 31st, 2023, which was filed on February 29th, 2024 and subsequent SEC filings. Except as required by law, Abbott

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot